• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Oppenheimer Appoints James Yoo Managing Director in Healthcare Equity Capital Markets Investment Banking

    10/6/25 6:00:00 AM ET
    $OPY
    Investment Bankers/Brokers/Service
    Finance
    Get the next $OPY alert in real time by email

    Seasoned industry professional brings 27 years of experience to expanding Healthcare platform

    NEW YORK, Oct. 6, 2025 /PRNewswire/ -- Oppenheimer & Co. Inc. ("Oppenheimer") — a leading investment bank, wealth manager, and a subsidiary of Oppenheimer Holdings (NYSE:OPY) — today announced that James Yoo has been named a Managing Director within its Healthcare Equity Capital Markets Investment Banking Group. In this role, Mr. Yoo will focus on Biotechnology Equity Capital Markets transactions.

    With 27 years of experience, Mr. Yoo has developed deep expertise in a range of financing structures, including Private Investment in Public Equity (PIPEs), Follow-on Offerings, Confidentially Marketed Public Offerings (CMPOs) and Registered Direct transactions.

    "James brings an exceptional track record of execution and deep relationships across the biotechnology investment community to his new role," said Peter Bennett, Managing Director and Head of Equity Capital Markets Investment Banking at Oppenheimer. "His ability to navigate complex financing structures will further strengthen Oppenheimer's leadership in Healthcare Equity Capital Markets."

    Before stepping into his new role, Mr. Yoo served as the Healthcare Specialist on Oppenheimer's Sales & Trading Desk since 2023, advising healthcare-dedicated investment funds and early- and late-stage biotechnology companies. Prior to Oppenheimer, he held various positions at leading firms such as Piper Sandler, Mizuho, and Nomura.

    "I am honored to join Oppenheimer's Healthcare Equity Capital Markets Investment Banking Group at such an exciting time for the biotechnology sector," Yoo said. "The firm's collaborative culture and broad platform create an exceptional environment to deliver innovative capital markets solutions. I look forward to working with my colleagues to help biotech companies access the financing they need to advance groundbreaking science and improve patient outcomes."

    About Oppenheimer Holdings Inc.

    Oppenheimer Holdings Inc., through its Oppenheimer & Co. Inc. subsidiary, and related entities, provides a full range of wealth management, securities brokerage, and investment banking services to high-net-worth individuals, families, corporate executives, businesses, and institutions. For more information, please visit www.oppenheimer.com.

    Media Contact:

    Joseph Kuo / Michael Dugan

    Haven Tower Group LLC

    424 317 4851 or 424 317 4852

    [email protected] or [email protected]

    Cision View original content:https://www.prnewswire.com/news-releases/oppenheimer-appoints-james-yoo-managing-director-in-healthcare-equity-capital-markets-investment-banking-302574286.html

    SOURCE Oppenheimer & Co. Inc.

    Get the next $OPY alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $OPY

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $OPY
    SEC Filings

    View All

    SEC Form DEF 14A filed by Oppenheimer Holdings Inc.

    DEF 14A - OPPENHEIMER HOLDINGS INC (0000791963) (Filer)

    3/13/26 8:05:45 AM ET
    $OPY
    Investment Bankers/Brokers/Service
    Finance

    SEC Form PRE 14A filed by Oppenheimer Holdings Inc.

    PRE 14A - OPPENHEIMER HOLDINGS INC (0000791963) (Filer)

    3/2/26 8:27:31 AM ET
    $OPY
    Investment Bankers/Brokers/Service
    Finance

    SEC Form 10-K filed by Oppenheimer Holdings Inc.

    10-K - OPPENHEIMER HOLDINGS INC (0000791963) (Filer)

    2/26/26 4:20:45 PM ET
    $OPY
    Investment Bankers/Brokers/Service
    Finance

    $OPY
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Glasser Teresa acquired 1,400 units of Class A non-voting common stock, increasing direct ownership by 8% to 18,400 units (SEC Form 4)

    4 - OPPENHEIMER HOLDINGS INC (0000791963) (Issuer)

    3/3/26 12:40:45 PM ET
    $OPY
    Investment Bankers/Brokers/Service
    Finance

    Director Roth R Lawrence acquired 1,400 units of Class A non-voting common stock, increasing direct ownership by 8% to 18,400 units (SEC Form 4)

    4 - OPPENHEIMER HOLDINGS INC (0000791963) (Issuer)

    3/3/26 12:40:26 PM ET
    $OPY
    Investment Bankers/Brokers/Service
    Finance

    Secretary Mcnamara Dennis P sold $423,701 worth of Class A non-voting common stock (4,673 units at $90.67), decreasing direct ownership by 19% to 20,177 units (SEC Form 4)

    4 - OPPENHEIMER HOLDINGS INC (0000791963) (Issuer)

    3/3/26 12:40:03 PM ET
    $OPY
    Investment Bankers/Brokers/Service
    Finance

    $OPY
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Oppenheimer Expands Municipal Capital Markets Platform with Three Managing Director Hires

    Additions coincide with growing infrastructure demand, a retreat by longtime market participants, and continued momentum in the firm's Public Finance businessNEW YORK, March 31, 2026 /PRNewswire/ -- Oppenheimer & Co. Inc. (Oppenheimer), a leading investment bank, wealth manager, and subsidiary of Oppenheimer Holdings Inc. (NYSE:OPY), today announced the hiring of three Managing Directors: Matt Davis, Head of Competitive Municipal Underwriting; Lauren Carter, Competitive Municipal Underwriting; and Brendan Shanahan, Municipal Trading. The three hires significantly expand the firm's municipal underwriting, sales and trading capabilities and build on the strong momentum of Oppenheimer's broader

    3/31/26 9:00:00 AM ET
    $OPY
    Investment Bankers/Brokers/Service
    Finance

    Oppenheimer Appoints Chris DeFalco And John Hyland As Co-Heads Of Equity Capital Markets

    Peter Bennett to Lead Corporate Executive Services TeamNEW YORK, March 24, 2026 /PRNewswire/ -- Oppenheimer & Co. Inc. (Oppenheimer), a leading investment bank, wealth manager, and subsidiary of Oppenheimer Holdings Inc., today announced that Managing Directors Chris DeFalco and John Hyland have been named Co-Heads of the firm's Equity Capital Markets Investment Banking group. In their new roles, they will jointly oversee the strategic direction, execution, and continued growth of Oppenheimer's leading equity capital markets platform, with a focus on deepening Oppenheimer's product expertise across its core industry verticals. Both will also serve on the firm's Investment Banking Commitment

    3/24/26 6:00:00 AM ET
    $OPY
    Investment Bankers/Brokers/Service
    Finance

    Oppenheimer Names Eric Nortman Head of Debt Private Placements

    Private credit executive to lead newly launched debt private placements group, expanding financing solutions for investment banking clients.NEW YORK, March 17, 2026 /PRNewswire/ -- Oppenheimer & Co. Inc. – a leading investment bank, wealth manager and a subsidiary of Oppenheimer Holdings Inc. (NYSE:OPY) – today announced that Eric Nortman has joined the firm as Managing Director, Head of Debt Private Placements. The move marks an expansion of the firm's financing solutions for its investment banking clients. In this role, Nortman will be based in New York and will report to Rob Lowenthal and Gilbert Dychiao, Co-Heads of Investment Banking at Oppenheimer.Nortman will lead the Debt Private Pla

    3/17/26 6:00:00 AM ET
    $OPY
    Investment Bankers/Brokers/Service
    Finance

    $OPY
    Leadership Updates

    Live Leadership Updates

    View All

    Oppenheimer Appoints Chris DeFalco And John Hyland As Co-Heads Of Equity Capital Markets

    Peter Bennett to Lead Corporate Executive Services TeamNEW YORK, March 24, 2026 /PRNewswire/ -- Oppenheimer & Co. Inc. (Oppenheimer), a leading investment bank, wealth manager, and subsidiary of Oppenheimer Holdings Inc., today announced that Managing Directors Chris DeFalco and John Hyland have been named Co-Heads of the firm's Equity Capital Markets Investment Banking group. In their new roles, they will jointly oversee the strategic direction, execution, and continued growth of Oppenheimer's leading equity capital markets platform, with a focus on deepening Oppenheimer's product expertise across its core industry verticals. Both will also serve on the firm's Investment Banking Commitment

    3/24/26 6:00:00 AM ET
    $OPY
    Investment Bankers/Brokers/Service
    Finance

    Oppenheimer Names Eric Nortman Head of Debt Private Placements

    Private credit executive to lead newly launched debt private placements group, expanding financing solutions for investment banking clients.NEW YORK, March 17, 2026 /PRNewswire/ -- Oppenheimer & Co. Inc. – a leading investment bank, wealth manager and a subsidiary of Oppenheimer Holdings Inc. (NYSE:OPY) – today announced that Eric Nortman has joined the firm as Managing Director, Head of Debt Private Placements. The move marks an expansion of the firm's financing solutions for its investment banking clients. In this role, Nortman will be based in New York and will report to Rob Lowenthal and Gilbert Dychiao, Co-Heads of Investment Banking at Oppenheimer.Nortman will lead the Debt Private Pla

    3/17/26 6:00:00 AM ET
    $OPY
    Investment Bankers/Brokers/Service
    Finance

    Oppenheimer Appoints Vien Le As Managing Director

    Seasoned municipal finance leader joins the firm's Public Finance Investment Banking Group and will be based in Los AngelesNEW YORK, Feb. 25, 2026 /PRNewswire/ -- Oppenheimer & Co. Inc. (Oppenheimer), a leading investment bank, wealth manager and a subsidiary of Oppenheimer Holdings Inc. (NYSE:OPY), today announced it has hired Vien Le as Managing Director in the firm's Public Finance Investment Banking Group. Le will be based in Oppenheimer's Los Angeles office and will report to Beth Coolidge, Managing Director and Head of Public Finance. Vien Le joins Oppenheimer with more than two decades of municipal finance experience advising public-sector clients on complex financings across a range

    2/25/26 6:00:00 AM ET
    $OPY
    Investment Bankers/Brokers/Service
    Finance

    $OPY
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G/A filed by Oppenheimer Holdings, Inc. (Amendment)

    SC 13G/A - OPPENHEIMER HOLDINGS INC (0000791963) (Subject)

    9/23/21 3:31:42 PM ET
    $OPY
    Investment Bankers/Brokers/Service
    Finance

    SEC Form SC 13G filed by Oppenheimer Holdings, Inc.

    SC 13G - OPPENHEIMER HOLDINGS INC (0000791963) (Subject)

    6/25/21 2:44:05 PM ET
    $OPY
    Investment Bankers/Brokers/Service
    Finance

    $OPY
    Financials

    Live finance-specific insights

    View All

    Oppenheimer Holdings Inc. Reports Fourth Quarter and Full Year 2025 Earnings

    NEW YORK, Jan. 30, 2026 /CNW/ - Oppenheimer Holdings Inc. (NYSE:OPY) (the "Company" or "Firm") today reported net income of $74.4 million or $7.08 basic earnings per share for the fourth quarter of 2025 compared with net income of $10.7 million or $1.04 basic earnings per share for the fourth quarter of 2024, an increase of 593.1%. Revenue for the fourth quarter of 2025 was $472.6 million compared to revenue of $375.4 million for the fourth quarter of 2024, an increase of 25.9%.  For the year ended December 31, 2025, the Company reported net income of $148.4 million or $14.13 basic earnings per share compared with net income of $71.6 million or $6.91 basic earnings per share for the year en

    1/30/26 8:00:00 AM ET
    $OPY
    Investment Bankers/Brokers/Service
    Finance

    OPPENHEIMER HOLDINGS INC. DECLARES SPECIAL DIVIDEND

    NEW YORK, Dec. 12, 2025 /PRNewswire/ - Oppenheimer Holdings Inc. (NYSE:OPY) today announced that its Board of Directors has declared a special cash dividend on OPY Class A non-voting and Class B voting common stock of $1.00 per share, payable January 9, 2026, to shareholders of record as of the close of business on December 26, 2025. The aggregate payment will be approximately $10.5 million. The special dividend will be funded through OPY's existing cash management activities. Robert S. Lowenthal, President and Chief Executive Officer, commented: "We are pleased to recognize the year's operating results and our improved financial position through the announcement of a special dividend of $1

    12/12/25 8:00:00 AM ET
    $OPY
    Investment Bankers/Brokers/Service
    Finance

    Oppenheimer Holdings Inc. Reports Third Quarter 2025 Earnings

    NEW YORK, Oct. 31, 2025 /PRNewswire/ - Oppenheimer Holdings Inc. (NYSE:OPY) (the "Company" or "Firm") today reported net income of $21.7 million or $2.06 basic earnings per share for the third quarter of 2025, compared with net income of $24.5 million or $2.38 basic earnings per share for the third quarter of 2024. Third quarter 2025 results were significantly impacted by higher pre-tax compensation expenses for liability-based awards totaling $13.5 million or $0.95 basic earnings per share (after tax), attributable to an increase in the OPY Class A share price (increased $8.30 per share during the quarter). Revenue for the third quarter of 2025 was $424.4 million, an increase of 13.7%, comp

    10/31/25 8:00:00 AM ET
    $OPY
    Investment Bankers/Brokers/Service
    Finance